Human monoclonal antibodies to herpes simplex virus and methods therefor
US6156313A · kind A · utility
17Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1997 |
| Grant date | Dec 5, 2000 |
| Priority date | — |
| Expiry date | May 6, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes human monoclonal antibodies which immunoreact with Herpes simplex virus Type-1 and Type-2. Also disclosed are immunotherapeutic and diagnostic methods of using the monoclonal antibodies, as well as nucleic acids and cell lines for producing the monoclonal antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.